Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Julphar
Merck
Deloitte
Cipla
Harvard Business School
US Army
UBS
McKinsey

Generated: April 22, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Roxicodone

« Back to Dashboard

Bulk Pharmaceutical API Sources for Roxicodone

Vendor Vendor Homepage Vendor Sku API Url
Hangzhou APIChem Technology ➤ Sign Up AC-16043 ➤ Sign Up
ABI Chem ➤ Sign Up AC1Q4DTG ➤ Sign Up
ChemMol ➤ Sign Up 30105082 ➤ Sign Up
AKos Consulting & Solutions ➤ Sign Up AKOS015962233 ➤ Sign Up
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Chinese Patent Office
Moodys
McKesson
QuintilesIMS
Cerilliant
Julphar
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.